Oral-contraceptive use in relation to myocardial infarction.
The effect of oral-contraceptive use on the risk of myocardial infarction and, in particular, the possible accentuation of that effect by cigarette smoking, was investigated in 234 premenopausal women with a first infarction and 1742 hospital controls. The overall rate ratio estimate of acute myocardial infarction for women who had used oral contraceptives in the preceding month was 4.0 (95% confidence interval, 2.5--6.3). Women who smoked heavily and used oral contraceptives had a point estimate of 39 (lower two-sided 95% confidence limit, 22) compared with those who did neither. This value was appreciably larger than could be accounted for by the separate effects of cigarettes and oral contraceptives, and this suggests a considerable accentuation by cigarette smoking of the effect of oral contraceptive use on myocardial infarction.
D000208:Acute Disease; D000328:Adult; D001900:Boston; D003276:Contraceptives, Oral / Q000009:adverse effects*; D004997:Ethinyl Estradiol / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008656:Mestranol / Q000008:administration & dosage / Q000009:adverse effects*; D008875:Middle Aged; D009203:Myocardial Infarction / Q000453:epidemiology*; D009518:New York; D009519:New York City; D010414:Pennsylvania; D011159:Population Surveillance; D012306:Risk; D012907:Smoking / Q000150:complications
D003276:Contraceptives, Oral; D004997:Ethinyl Estradiol; D008656:Mestranol